Retour
Fourchette du Jour
735,40 €
750,00 €
Fourchette 52 Semaines
476,49 €
821,11 €
Volume
510 002
Moyenne 50J / 200J
766,57 €
/
651,78 €
Clôture Précédente
732,87 €
Historique des Prix
Tendances Financières
Comparaison Sectorielle
vs médiane du secteur Healthcare (626 pairs)
| Métrique | Action | Médiane du Secteur |
|---|---|---|
| P/E | 17,0 | 0,4 |
| P/B | 2,5 | 2,9 |
| ROE % | 14,9 | 3,7 |
| Net Margin % | 31,4 | 3,9 |
| Rev Growth 5Y % | -2,8 | 10,0 |
| D/E | 0,1 | 0,2 |
Objectif de Cours des Analystes
Hold
862,74 €
+17.1%
Low: 700,00 €
High: 1 057,00 €
P/E Prévisionnel
16,2
BPA Prévisionnel
45,38 €
Croissance BPA (est.)
+0,0%
CA Est.
16 B
Estimations de Bénéfices
| Période | BPA Est. | CA Est. | Analystes |
|---|---|---|---|
| FY2030 |
71,97 €
64,90 € – 79,90 €
|
21 B | 2 |
| FY2029 |
67,38 €
60,76 € – 74,80 €
|
20 B | 4 |
| FY2028 |
60,83 €
48,91 € – 72,26 €
|
19 B | 6 |
Points Clés
Revenue declined -2,81% annually over 5 years
ROE of 14,87% — decent returns on equity
Net margin of 31,41% shows strong profitability
Debt/Equity of 0,09 — conservative balance sheet
Generating 4,08B in free cash flow
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 3,80%
Croissance
Revenue Growth (5Y)
-2,81%
Revenue (1Y)0,99%
Earnings (1Y)2,09%
FCF Growth (3Y)5,48%
Qualité
Return on Equity
14,87%
ROIC7,90%
Net Margin31,41%
Op. Margin24,95%
Sécurité
Debt / Equity
0,09
Current Ratio4,13
Interest Coverage81,69
Valorisation
P/E Ratio
16,99
P/B Ratio2,45
EV/EBITDA21,27
Dividend Yield0,00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,99% | Revenue Growth (3Y) | 4,57% |
| Earnings Growth (1Y) | 2,09% | Earnings Growth (3Y) | 6,74% |
| Revenue Growth (5Y) | -2,81% | Earnings Growth (5Y) | -13,58% |
| Profitability | |||
| Revenue (TTM) | 14,34B | Net Income (TTM) | 4,50B |
| ROE | 14,87% | ROA | 11,11% |
| Gross Margin | 85,35% | Operating Margin | 24,95% |
| Net Margin | 31,41% | Free Cash Flow (TTM) | 4,08B |
| ROIC | 7,90% | FCF Growth (3Y) | 5,48% |
| Safety | |||
| Debt / Equity | 0,09 | Current Ratio | 4,13 |
| Interest Coverage | 81,69 | Dividend Yield | 0,00% |
| Valuation | |||
| P/E Ratio | 16,99 | P/B Ratio | 2,45 |
| P/S Ratio | 5,34 | PEG Ratio | 3,38 |
| EV/EBITDA | 21,27 | Dividend Yield | 0,00% |
| Market Cap | 76,53B | Enterprise Value | 76,12B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 14,34B | 14,20B | 13,12B | 12,17B | 16,07B |
| Net Income | 4,50B | 4,41B | 3,95B | 4,34B | 8,08B |
| EPS (Diluted) | 41,48 | 38,34 | 34,77 | 38,22 | 71,97 |
| Gross Profit | 12,24B | 12,23B | 10,87B | 10,47B | 13,35B |
| Operating Income | 3,58B | 3,99B | 4,35B | 5,39B | 8,95B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 40,56B | 37,76B | 33,08B | 29,21B | 25,43B |
| Total Liabilities | 9,30B | 8,41B | 7,11B | 6,55B | 6,67B |
| Shareholders' Equity | 31,26B | 29,35B | 25,97B | 22,66B | 18,77B |
| Total Debt | 2,71B | 2,70B | 2,70B | 2,70B | 2,70B |
| Cash & Equivalents | 3,12B | 2,49B | 2,73B | 3,11B | 2,89B |
| Current Assets | 18,02B | 18,66B | 19,48B | 15,88B | 14,01B |
| Current Liabilities | 4,37B | 3,94B | 3,42B | 3,14B | 3,93B |